M Quintela-Fandino, E Holgado, L Manso… - Breast Cancer …, 2020 - Springer
Background Preclinical research suggests that the efficacy of immune checkpoint inhibitors
in breast cancer can be enhanced by combining them with antiangiogenics, particularly in a …